Preventive Measures and Enhanced Health, Hygiene and Quality of Life of the Wider Community
Submitting Institution
University of BoltonUnit of Assessment
General EngineeringSummary Impact Type
HealthResearch Subject Area(s)
Engineering: Biomedical Engineering
Medical and Health Sciences: Clinical Sciences, Nursing
Summary of the impact
A novel pressure-relieving technology has been developed to enhance the
quality of life of a range
of people. This has enabled the development firstly of a novel compression
therapy system for the
prevention and treatment of venous leg ulcers especially for middle-aged
and older communities
as well as having the potential for huge savings to the NHS. Secondly, is
a unique pressure-relieving
cushion to reduce pressure sores with specific applications for wheelchair
users. Baltex
Ltd, UK are successfully producing both commercially. An exclusive
agreement has been signed
with a global medical device company, BSN Medical for marketing the
single-layer bandage.
Underpinning research
2.1. Medical Devices for Wound Management (refs 1 to 5)
It was established from the earlier research funded by the former UK DTI
that a novel compression
system is essential to address the problems associated with the multilayer
compression system for
the treatment of venous leg ulcers. The principal problems include uneven
pressure distribution
and an ineffective compression profile, which are considered to be
critical because high pressure
can damage the venous and arterial systems on the limb and the beneficial
effect is not attainable
if the compression system provides too low a pressure.
In the UK alone about 1% of the adult population suffers from venous
ulceration and the cost to the
NHS for the treatment is about £650million per annum. EPSRC acknowledged
the significance of
further research in this area and awarded a grant to Dr S.Rajendran (PI)
and Professor S.C.Anand
(CI) for designing and developing a single-layer compression therapy
system during 2005 - 2009.
A 3-dimensional single-layer bandage was developed and it possessed all
the desirable attributes
and sustained graduated pressure of the current four layer bandage system,
offering financial and
technological benefits to the NHS and other allied establishments in the
world.
Results from the associated project funded by NWDA/EPSRC (2005 - 2008)
paved the way for
developing a unique odour/volatile adsorbent wound dressing by making use
of the natural
polysaccharides in aloe vera. It should be stressed that the currently
available activated carbon
charcoal, odour-adsorbent dressing possesses some undesirable
characteristics besides
environmental concerns and therefore the situation demanded a need to
develop an alternative to
activated carbon charcoal-containing dressings. Under the leadership of
Professor Anand, the
team in which Dr Rajendran was a co-investigator has developed a novel
dressing that meets most
of the requirements of an ideal wound dressing in addition to odour
adsorption and antimicrobial
properties.
2.2. Pressure Relieving Cushion (ref 6)
This development has risen directly from the three-dimensional
single-layer venous leg ulcer
bandage, because high localised pressures experienced by patients' having
confined mobility,
including wheelchair users, can cause venous leg ulcers. Based on our
improved understanding on
the need to reduce localised pressure and the associated textile structure
developments which
have enabled this to be achieved, a novel pressure-relieving cushion has
been developed and fully
characterised (2009-2013) for the treatment and management of pressure
sores and other
diseases suffered by the wheelchair patients. Baltex Ltd, UK are currently
marketing the cushion
throughout the Europe and other countries. Professor Anand is the
Principal Investigator and Dr
Rajendran is the Co-investigator.
References to the research
1. G.Lee, S.Rajendran and S.C.Anand, Novel single layer compression
bandage system for the
treatment of chronic venous leg ulcers, British J Nursing, 18, 15, S4-S18
(2009).
2. G.Lee, S.C.Anand and S.Rajendran, Are Biopolymers Potential
Deodourising Agents in Wound
Management? Journal of Wound Care, 18, July, 290-295(2009).
3. S.Rajendran, S.C.Anand and G.Lee, A Novel Single Layer 3D Spacer
Bandage for Venous Leg
Ulcer Management, Wounds UK, Harrogate, 10 - 11 November 2008.
4. S.C.Anand and S.Rajendran, Development of 3-Dimensional structures for
Venous Leg Ulcer
Management, Fiber Med 11, International Conference on Medical and
Healthcare Devices,
Tampere, Finland, 28-30 June 2011.
5. S.Rajendran, S.C.Anand and C.Wood, Pressure Actuator, UK Patent: GB
1012671.2, 28 July
2010.
6. S.C.Anand, C.Wood and B.McArdle, Cushioning Fabrics, UK Patent: GB
1306094.2, 04 April
2013.
Details of the impact
The underpinning research described in this report has impacted
significantly on the lives of a
range of people by enhancing the hygiene and patient care through
prevention and treatment. The
venous leg ulcer research is highly significant mainly because it enhances
the quality of life of
middle-aged and older people to boost the cost saving for the NHS, which
is crucial in the current
economic climate. The novel single-layer bandage replaces the standard
four layer system.
The leg ulcer takes a long time to heal which can cause distress to
patients and also the treatment
cost is high to the NHS. About 1% of the adult population suffers from
active ulceration during their
lifetime. The prevalence of venous leg ulcer increases with age, from 1%
within the adult
population to 3.6% in the over 65 age group. The total cost to the NHS for
venous leg ulcer
treatment is about £650 million per annum, which is 1-2% of the total
healthcare expenditure. Cost
per patient has recently been estimated to be between £1200 and £1400. The
annual cost for
treating venous leg ulceration in the USA is between $1.9 billion and $2.5
billion and in Western
Europe it is 1% of the total annual healthcare budget.
It has been well established that compression therapy by making use of
compression bandages is
the `Gold Standard' for the treatment and prevention of venous leg ulcer
as there is no medication
or surgery to cure the ulcer. In the UK, a multilayer system (four layer
bandaging system) is widely
used whilst in Europe a two layer regime is popular.
With the above background, it is stressed that the impact and benefits
accrued from Bolton's
venous leg ulcer research are enormous both nationally and worldwide and
are highly significant.
The market revenues are expected to increase significantly after the
launch of the novel 3D single-layer
bandage because it offers cost-effective single-layer therapy, which would
replace the current
practice of multilayer bandage systems with enhanced functional properties
for treating venous leg
ulcers. Current competitors provide a multilayer compression system and
not a single company
currently offers a single-layer compression system. The research is
considered to be revolutionary
because currently no 3D single-layer bandage has been listed in the `Drug
Tariff' for use in the UK.
The novel compression regime is also much lighter, comfortable and can be
laundered up to 50
times.
Since the commercial exploitation of novel compression therapy deals with
people's healthcare,
the ultimate beneficiaries would be middle-aged and elderly patients
particularly women who are
more prone to developing venous leg ulcers. It is anticipated that
patients would feel utmost
comfort by having a single-layer bandage system, instead of multilayer
bandages, on their limbs. It
should be noted that the bandages stay on the limb for several weeks or
months because a typical
venous leg ulcer is a chronic condition which takes a long time to heel.
In contrast to the 3D single-layer
regimen, four layer regimes are bulky and cause discomfort to patients
because they are too
cumbersome.
Additional benefits to patients with single-layer bandages over
multilayer bandages are: a) they are
highly breathable; b) they provide good resilience and cushioning effects
due to the 3D cell
structure; and c) offering simplicity of application. Nurses, doctors and
other hospital staff will also
receive benefits through increased understanding of innovations and novel
practices accruing as a
direct result of this single-layer therapy. The novel single-layer 3D
bandage would subsequently
reduce leg ulcer healing times as well as nursing time and thus offers
financial and technological
benefits to the NHS and private hospitals. In contrast to a single-layer
system, the four layer
system consumes considerable nursing time. The current multilayer bandages
are manufactured
by using different technologies and equipment and the cost involved is
high. In contrast, the novel
single-layer 3D bandage is manufactured using only one machine and the
production cost is
comparatively low. Considering savings in the material and production
costs, in the nursing time
and in the time to heal the ulcers, it is estimated that a total saving of
around £60 million per
annum would be realised upon the successful launch of the single-layer
compression therapy. The
environmental aspects of this novel product are also extremely crucial.
The increased use of the
single-layer bandage, in contrast to four layer bandages, will enable the
establishment of a much
improved and efficient mode of clinical and medical waste disposal and
will result in a safer and
cleaner environment. Other direct beneficiaries include fibre
manufacturers, medical textile product
manufacturers, supply chains, and of course medical and scientific
communities in the UK and
worldwide. All these measures would ultimately boost the UK economy. A
patent has been applied
for and licensed to Baltex Ltd, UK who have successfully produced the
commercial product and an
exclusive agreement has been signed with a global medical device company,
BSN Medical for
marketing the single-layer bandage worldwide. The outcomes of the research
will pave the way for
developing future products for the treatment of varicose veins and DVT. It
is forecast by Baltex Ltd,
UK that a revenue of £100,000 in 2013 and £1.0 million after three years
would be achieved.
Underpinning the above research, Dr Rajendran was invited for
presentation meetings in India and
this yielded the academic collaboration with The South India Textile
Research Association (SITRA)
and PSG College of Technology (PSGT) in India. The University has signed a
Memorandum of
Understanding with SITRA in January 2010 which extends until July 2015.
This facilitates further
collaborative research in healthcare sector in the UK and India. An
international conference
highlighting the healthcare and hygiene was organised jointly with PSGT in
July 2010.
The sales projections for pressure relieving cushion for the treatment
and management of pressure
sores and other diseases suffered by the wheel chair patients would be
£40,000 in the first year
(2013) and £5.0 million in five years.
Some of other impact indicators include 10 refereed publications, 15
conference presentations, 8
book chapters, 4 patents and career development of 6 researchers.
Sources to corroborate the impact
- http://gow.epsrc.ac.uk/NGBOViewGrant.aspx?GrantRef=EP/C538196/1
- The Bolton News, 8 November 2011.
- Parliament Report, Research and Development Work Relating to Assistive
Technology
2008-09, Report Presented to Parliament by the Department of Health,
July 2009, Page 23.
- BBC Radio Manchester, Business Hour Interview, 5th April
2011.
- S.Rajendran, The Future of Medical Fibres and Biomaterials for
Healthcare and Hygiene
Market, Hohenstein Future Textile Symposium — Successful Strategies for
the World
Markets: How to get in the Growing Health Market with Innovative
Products, Hohenstein,
Germany, 19 February, 2008.
- S.Rajendran, Innovative Medical Fibres and Textile Medical Devices for
Healthcare and
Hygiene, EKOTEKS Symposium, Istanbul, Turkey, 12 March, 2008.
- S.Rajendran and S.C.Anand, Insight into the Development of a Novel
Single Layer
Bandaging Regime for the Treatment of Venous Leg Ulcers, 86th
Textile Institute's World
Conference, Hong Kong, 18 - 20 November 2008.
- S.Rajendran, S.C.Anand and G.Lee, Novel 3D Single-layer Compression
Bandage System
for the Treatment of Venous Leg Ulcers, The Bolton Research Forum in
Health and Social
care, Bolton, 30 June 2009.
- S.Rajendran, S.C.Anand and A.Afifi, A Novel Concept for Designing a
Single Layer
Compression Bandage System for the Treatment of Venous Leg Ulcers,
Ambience 08,
Boras, Sweden, 2 -3 June 2008.
- S.C.Anand, Development of 3-Dimensional Structures for Venous Leg
Ulcer Management,
3rd World Conference on 3-D Structures and their
Applications, Wuhan, China, 20-21 April,
2011.